Title : Site-specific modification of interleukin-2 by the combined use of genetic engineering techniques and transglutaminase.

Pub. Date : 1996 Oct 8

PMID : 8855943






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3). monodansylcadaverine interleukin 2 Homo sapiens
2 The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3). monodansylcadaverine transglutaminase 1 Homo sapiens
3 The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3). monodansylcadaverine interleukin 2 Homo sapiens
4 The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3). monodansylcadaverine transglutaminase 1 Homo sapiens